Talk:Gasbus - health impacts of Helsinki bus traffic

From Opasnet
Revision as of 19:42, 18 February 2008 by Mikko Pohjola (talk | contribs) (Suggestions of different groups for issue framing -- ~~~~)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Suggestions of different groups for issue framing -- Mikko Pohjola 21:42, 18 February 2008 (EET)

Päivi Meriläinen, Matteo Prandi, Antonio Gasparrini, Pauliina Ahtoniemi

Scope

Purpose

To compare PM2.5 induced mortality in alternative public bus-transportation strategies as being considered by the Helsinki Metropolitan area.

Boundaries

  • area: Helsinki Metropolitan area, Finland
  • population: whole population in Helsinki area (1 million)
  • primary PM2.5
  • time period: Based on data 1996-1997, projected to year 2020
  • Public Health effects: Mortality due to cardiopulmonary diseases, lung cancer and other non-accidental causes (?)
  • Bus traffic tail-pipe emissions
  • different ratio between the technologies
  • fuel


Scenarios

  1. Business as usual (current bus fleet)
  2. All buses converted to modern diesel (EURO3-STD)
  3. All buses converted to diesel with particle traps
  4. All buses converted to natural gas buses

Intended users

  • Helsinki Metropolitan area council
  • Finnish government (e.g. Finnish ministry of social affairs and health)
  • Scientific community
  • Decision makers at local community level

Participants

  • Scientists: KTL, YTV, Joint Research Centre @ European Commission

Definition

Variables

  • Decision variable: Which bus engine?
    • includes emissions from different engine types
  • PM2.5 emission from bus traffic
  • PM2.5 concentration of bus traffic in Helsinki area (= exposure and intake estimate)
    • data: total conc. of PM2.5 exposure in Helsinki
  • constant: Bus traffic intensity (if it remains the same)
  • Dose-response
    • slope uncertain à variable
    • background mortality included as a constant
  • human behavior (if data available)
  • Health impact à mortality rate